• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.64 Down 0.02(0.43%) Apr 17, 4:00PM EDT
    |After Hours : 4.65 Up 0.01 (0.22%) Apr 17, 5:57PM EDT
    Add to Portfolio
    Prev Close:4.66
    Open:4.61
    Bid:4.55 x 300
    Ask:4.65 x 3000
    1y Target Est:7.42
    Beta:-4.46
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:4.55 - 4.73
    52wk Range:3.26 - 7.22
    Volume:3,121,266
    Avg Vol (3m):4,968,260
    Market Cap:1.12B
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 0.43%1.12B
    GSKDown 0.61%113.76B
    OREXDown 3.33%932.90M
    RHHBYDown 1.53%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):30.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.53
    Quarterly EPS Est (Mar-15) :-0.14
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.43

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback